Oratrope (ibutamoren) / Merck (MSD), Lumos Pharma 
Welcome,         Profile    Billing    Logout  
 29 Diseases   4 Trials   4 Trials   103 News 
6 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Oratrope (ibutamoren) / Merck (MSD), Lumos Pharma
2020-000874-92: A Multicenter, 24-Month, Randomized, Open-Label, Active Control, Parallel Arm, Phase 2 Study of Daily Oral LUM-201 in Naïve-to-Treatment, Prepubertal Children with Idiopathic Growth Hormone Deficiency (GHD) Wieloośrodkowe, 24-miesięczne, Randomizowane, Otwarte, Kontrolowane, Równoramienne Badanie Fazy 2 z Podawanym Codziennie Doustnie LUM-201 Dzieciom Wcześniej Nieleczonym w Okresie Przedpokwitaniowym z Idiopatycznym Niedoborem Hormonu Wzrostu (GHD).

Not yet recruiting
2
80
Europe
LUM-201, Tablet, Injection, Norditropin
Lumos Pharma, Inc., Lumos Pharma
Growth hormone deficiency, Growth hormone deficiency, Diseases [C] - Hormonal diseases [C19]
 
 
OraGrowtH213, NCT05250063 / 2022-001695-34: Phase 2 Study of LUM-201 in Children Who Have Previously Completed the LUM-201-01 Trial

Active, not recruiting
2
18
Europe, US
LUM-201
Lumos Pharma
Growth Hormone Deficiency
02/25
02/25
OraGrowtH210, NCT04614337 / 2020-000874-92: Phase 2 Study of LUM-201 in Children With Growth Hormone Deficiency ( Trial)

Completed
2
82
Europe, US, RoW
LUM-201, rhGH Norditropin® pen (34 µg/kg)
Lumos Pharma, Lumos Pharma
Growth Hormone Deficiency
09/24
09/24
NCT05364684: The Impact of Ibutamoren on Nonalcoholic Fatty Liver Disease

Active, not recruiting
2
12
US
LUM-201, Ibutamoren Mesylate
Massachusetts General Hospital
NAFLD, Nonalcoholic Fatty Liver, NASH - Nonalcoholic Steatohepatitis
02/25
02/25
OraGrowtH211, NCT05796440: A Long-Term Safety Trial of LUM-201 in Children With Idiopathic Growth Hormone Deficiency Who Have Previously Completed a LUM-201 Clinical Trial

Enrolling by invitation
2
60
US, RoW
LUM-201
Lumos Pharma
Growth Hormone Deficiency
03/28
04/28
OraGrowtH212, NCT04806854: PK and PD Study of LUM-201 in Children With Idiopathic Growth Hormone Deficiency:

Active, not recruiting
2
24
RoW
LUM-201
Lumos Pharma
Growth Hormone Deficiency
04/30
07/30

Download Options